Potassium Chloride
Product Images NDC 57297-798

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Potassium Chloride (NDC 57297-798). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Potassium Chloride Extended-release Capsules Usp600 mg (8 Meq K) Ndc 68180-798-01 (Bottle of 100s)

These are potassium chloride extended-release capsules USP, containing 600mg (8 mEq K) of microencapsulated KC1, designed to release the active ingredient over 8-10 hours. The usual dosage is outlined in an accompanying prescribing information. It is for Rx use only and is stored at 25°C (77°F), with possible excursions within a range of 15°C to 30°C (59°F to 86°F). It is dispensed in a tight container as defined in the USP. Manufactured for Lupin Pharmaceuticals in Maryland, USA, by Lupin Limited in Pithampur, India. Lot number is BR and the manufacturing date is ML 25/8/2010.*

FDA Label Image

Potassium Chloride Extended-release Capsules Usp750 mg (10 Meq K) Ndc 68180-799-01 (Bottle of 100s)

This is a description of Potassium Chloride Extended-Release capsules from Lupin Pharmaceuticals. The capsules contain 750mg of Potassium Chloride (10 mEq K) and are designed to release the active ingredient over a 6 to 10 hour period. The capsules come in a pack of 100 and should be stored at 25°C (77°F). The usual dosage is not specified, and users should refer to the accompanying prescribing information. The manufacturer is located in Baltimore, Maryland, and the capsules are manufactured in India.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.